PEPTIDE BASED INFECTION THERAPEUTICS MARKET ANALYSIS
Peptide Based Infection Therapeutics Market – Regional Analysis
On the basis of region, the Peptide Based Infection Therapeutics Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America expected to show higher market attractiveness and domination over other regions due to new advancements in treatment such as peptide vaccines, and presence of large number of peptide manufacturing companies. In 2014-2015, AmbioPharm, Inc., a company of U.S., is manufacturing peptide based antifungals with better efficacy. This company has also expanded its manufacturing units in America and China to meet the demands.
Furthermore, high number of morbidity of infectious diseases is also driving the growth of market in U.S. For instance, According to World Health Organization (WHO) 2016 statistics, in U.S., number of new tuberculosis cases were 9,272 and number of new salmonella cases were 53,850.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
